Here's the live share price of Sanofi India along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Sanofi India | 6.31 | -4.81 | -15.24 | -26.24 | -43.88 | -16.64 | -15.59 |
| Sun Pharmaceutical Industries | -2.52 | -9.47 | -4.89 | -0.99 | -2.11 | 17.86 | 21.69 |
| Divi's Laboratories | 3.42 | -4.59 | -6.64 | -7.58 | 8.31 | 27.43 | 9.87 |
| Torrent Pharmaceuticals | 4.43 | -5.94 | 5.52 | 18.36 | 33.21 | 38.82 | 26.66 |
| Lupin | 1.73 | -1.25 | 5.77 | 17.55 | 17.63 | 51.94 | 17.24 |
| Dr. Reddy's Laboratories | 1.43 | -6.83 | 1.59 | -2.14 | 11.35 | 9.02 | 4.36 |
| Cipla | 1.50 | -8.92 | -17.38 | -22.55 | -17.21 | 10.12 | 6.05 |
| Zydus Lifesciences | 6.45 | -0.22 | 2.79 | -7.40 | 5.96 | 22.47 | 12.97 |
| Mankind Pharma | 4.10 | -7.31 | -6.63 | -14.84 | -11.57 | 13.45 | 7.86 |
| Aurobindo Pharma | 0.28 | 2.69 | 14.24 | 17.85 | 23.75 | 35.14 | 7.90 |
| Alkem Laboratories | 1.95 | -3.16 | -8.67 | -2.52 | 9.82 | 17.16 | 14.32 |
| Glenmark Pharmaceuticals | 5.07 | -3.17 | 9.03 | 15.15 | 59.74 | 65.52 | 34.59 |
| Laurus Labs | 4.19 | 4.60 | 4.38 | 24.22 | 79.50 | 53.21 | 21.19 |
| Biocon | -2.16 | -12.75 | -7.28 | -1.25 | 8.97 | 16.91 | -3.12 |
| Abbott India | -2.32 | -5.68 | -9.68 | -14.34 | -13.23 | 4.08 | 11.25 |
| Anthem Biosciences | 10.37 | 12.54 | 18.16 | -7.01 | -0.08 | -0.03 | -0.02 |
| GlaxoSmithKline Pharmaceuticals | 4.06 | -3.25 | 0.24 | -12.60 | -12.48 | 23.32 | 10.58 |
| Ipca Laboratories | -2.30 | -5.25 | -5.01 | 9.74 | 9.02 | 20.52 | 6.16 |
| Ajanta Pharma | 3.61 | -4.91 | 5.92 | 19.77 | 12.82 | 31.15 | 20.46 |
| J B Chemicals & Pharmaceuticals | 2.00 | -6.07 | 6.34 | 20.03 | 26.74 | 25.37 | 26.80 |
Over the last one year, Sanofi India has declined 43.88% compared to peers like Sun Pharmaceutical Industries (-2.11%), Divi's Laboratories (8.31%), Torrent Pharmaceuticals (33.21%). From a 5 year perspective, Sanofi India has underperformed peers relative to Sun Pharmaceutical Industries (21.69%) and Divi's Laboratories (9.87%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 3,291.54 | 3,425.52 |
| 10 | 3,283.74 | 3,392.91 |
| 20 | 3,425.79 | 3,446.52 |
| 50 | 3,783.62 | 3,678.23 |
| 100 | 4,024.21 | 3,986.91 |
| 200 | 4,661.4 | 4,495.48 |
In the latest quarter, Sanofi India remained same as its previous close in promoter holding, while DII stake decreased to 21.30%, FII holding fell to 5.55%, and public shareholding moved up to 12.75% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 65,268 | 1.99 | 25.88 | |
| 63,911 | 0.09 | 25.34 | |
| 22,295 | 0.24 | 8.84 | |
| 11,397 | 0.51 | 4.52 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Apr 10, 2026, 03:12 AM IST IST | Sanofi India - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Apr 03, 2026, 01:26 AM IST IST | Sanofi India - Communication Of Tax Deduction At Source On Final Dividend For The Financial Year Ended December 31, 2025 |
| Apr 03, 2026, 01:24 AM IST IST | Sanofi India - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 |
| Apr 03, 2026, 01:19 AM IST IST | Sanofi India - Intimation Regarding Receipt Of Central Government Approval For Appointment Of The Managing Director Of The Co |
| Apr 02, 2026, 08:58 PM IST IST | Sanofi India - Business Responsibility and Sustainability Reporting (BRSR) |
Sanofi India Ltd. is a Public Limited Listed company incorporated on 02/05/1956 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1956PLC009794 and registration number is 009794. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 1837.40 Cr. and Equity Capital is Rs. 23.00 Cr. for the Year ended 31/12/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Sanofi India is ₹3,471.00 as on Apr 13, 2026.
The Sanofi India is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Sanofi India is ₹7,993.93 Cr as on Apr 13, 2026.
Today’s highest and lowest price of Sanofi India are ₹3,477.50 and ₹3,399.40.
The 52-week high/low is the highest and lowest price at which Sanofi India stock has traded in the past 52-week or nearly a year. The 52-week high of Sanofi India is ₹6,717.50 and 52-week low of Sanofi India is ₹3,151.05 as on Apr 13, 2026.
The Sanofi India has shown returns of -0.64% over the past day, -4.81% for the past month, -15.24% over 3 months, -43.88% over 1 year, -16.64% across 3 years, and -15.59% over 5 years.
P/E ratio of and PB ratio of Sanofi India are 19.34 and 10.42 on Apr 13, 2026. While the company gives a dividend yield of 2.16 per annum.